Therapy of Obstructive and Central Sleep Apnea in Patients with Congestive Heart Failure

Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease: Volume 146

Volumn 146, Issue , 2000, Pages 461-495

  Tkacova, Ruzena ^a   Bradley, T Douglas ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001776632     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15277-24     Document Type: Chapter

References (131)

1. McAlister FA, Teo KK. The management of congestive heart failure. Postgrad Med J 1997; 73:194-200.
2. Kannel WB, Belanger AJ. Epidemiology in heart failure (abstr). Am Heart J 1991; 121:951-957.
3. Yusuf S, Thom T, Abbot RD. Changes in hypertension treatment and congestive heart failure mortality in the Unites States. Hypertension 1989; 13(suppl 1):1174-1179.
4. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976; 27:465-484.
5. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension: a population-based study. Ann Intern Med 1994; 120:382-388.
6. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994; 150:72-77.
7. Javaheri S, Parker TJ, Wexler L, Michaels SE, Stanberry E, Nishyama H, Roselle GA. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122:487-492.
8. Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151:92-97.
9. Bradley TD, Floras JS. Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure. J Cardiac Failure 1996; 2:223-240.
10. Andreas, S, Hagenah G, Moller C, Werner GS, Kreuzer H. Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol 1996; 78:1260-1264.
11. Findley LJ, Zwillich CW, Ancoli-Israel S, Kripke D, Tisi G, Moser KM. Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 1985; 78:11-15.
12. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996; 153:272-276.
13. Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338:1480-1484.
14. Takasaki Y, Orr D, Popkin J, Rutherford R, Liu P, Bradley TD. Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure. Am Rev Respir Dis 1989; 140:1578-1584.
15. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157:1746-1752.
16. Palomaki H, Partinin M, Juvela S, Kaste M. Snoring as a risk factor for sleep-related brain infarction. Stroke 1989; 10:1311-1315.
17. Hanly P, Sasson Z, Zuberi N, Lunn K. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993; 71:1341-1345.
18. Franklin KA, Nilsson JB, Sahlin C. Sleep apnoea and nocturnal angina. Lancet 1995; 345:1085-1087.
19. Tkacova R, Rankin F, Fitzgerald F, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998; 98:2269-2275.
20. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998; 97:21542159.
21. Young TB, Palta M, Dempsey JA, Skatrud JB, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
22. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991; 46:85-89.
23. Horner RL, Mohiaddin RH, Lowell DG, Shea SA, Burman ED, Longmore DB, Guz A. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989; 2:613622.
24. Brown IG, Bradley TD, Phillipson EA, Zamel N, Hoffstein V. Pharyngeal compliance in snoring subjects with and without sleep apnea. Am Rev Respir Dis 1985; 132:211-215.
25. Issa FG, Sullivan CE. Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol 1984; 57:520-527.
26. Rubinstein I, Colapinto N, Rotstein LE, Brown IG, Hoffstein V. Improvement in pharyngeal properties after weight loss in patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138:1192-1195.
27. Bonora M, Shields GI, Knuth SL, Bartlett D Jr, St John WM. Selective depression by ethanol of upper airway respiratory motor activity in cats. Am Rev Respir Dis 1984; 130:156-161.
28. Bonora M, St John WM, Bledsoe TA. Differential elevation by protryptyline and depression by diazepam of upper airway respiratory motor activity. Am Rev Respir Dis 1985; 131:41-45.
29. Issa FG, Sullivan CE. Alchohol, snoring, and sleep apnea. J Neurol Neurosurg Psychiatry 1982; 45:353-359.
30. Mendelson WB, Garnett D, Gillin JC. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Neurol MentDis 1981; 169:261-264.
31. George CF, Millar TW, Kryger MH. Sleep apnea and body position during sleep. Sleep 1988; 11:90-99.
32. Shepard JW Jr, Pevernagie DA, Stanson AW, Daniels BK, Sheedy PF. Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 153:250-254.
33. Hoffstein V. How and why should we stabilize the upper airway? Sleep 1996; 19: S57-S60.
34. Naughton MT, Rahman MA, Hara K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91:1725-1731.
35. McGregor M, Becklake MR. The relationship of oxygen cost of breathing to respiratory mechanical work and respiratory force. J Clin Invest 1961; 40:971-980.
36. Manyari DE, Wang Z, Cohen J, Tyberg JV. Assessment of human splanchnic vol-ume-pressure relation using radionuclide plethysmography: effect of nitroglycerine. Circulation 1993; 87:1142-1151.
37. Lenique F, Habis M, Lofaso F, Dubois-Rnade JL, Harf A, Brochard L. Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med 1997; 155:500-505.
38. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990; 8:941-946.
39. Somers VK, Dyken ME, Clary MP, Abbound FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
40. Barruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991; 14:83-86.
41. Butler GC, Naughton MT, Rahman MA, Bradley TD, Floras JS. Continuous positive airway pressure increases heart rate variability in congestive heart failure (see comments). J Am Coll Cardiol 1995; 25:672-679.
42. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart rate variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993; 21:729-736.
43. Pinsky MR, Matuschak GM, Klain M. Determinants of cardiac augmentation by elevations in intrathoracic pressure. J Appl Physiol 1985; 58:1189-1198.
44. Pinsky MR, Summer WR, Wise RA, Permutt S, Brobmerger-Barnea B. Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol 1983; 54:950-955.
45. Fewell JE, Abendschein DR, Carlson CJ, Murray JF, Rapaport E. Continuous posi-tive-pressure ventilation decreases right and left ventricular end-diastolic volumes in the dog. Circ Res 1980; 46:125-132.
46. Johnston WE, Vinten-Johansen J, Santamore WP, Case LD, Little WC. Mechanisms of reduced cardiac output during positive end expiratory pressure in the dog. Am Rev Respir Dis 1919; 140:1257-1264.
47. Bradley TD, Holloway RM, McLaughlin PR, Ross BL, Walters J, Liu PP. Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 1992; 145:377-382.
48. De Hoyos A, Liu PP, Benard DC, Bradley TD. Haemodynamic effects of continuous positive airway pressure in humans with normal and impaired left ventricular function. Clin Sci (Colch) 1995; 88:173-178.
49. Genovese J, Moskowitz M, Tarasiuk A, Graver LM, Scharf SM. Effects of continuous positive airway pressure on cardiac output in normal and hypervolemic unanesthetized pigs. Am J Respir Crit Care Med 1994; 150:752-758.
50. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336:261-264.
51. Galatius-Jensen S, Hansen J, Rasmussen V, Bildsoe J, Therboe M, Rosenberg J. Nocturnal hypoxaemia after myocardial infarction: association with nocturnal myocardial ischaemia and arrhythmias. Br Heart J 1994; 72:23-30.
52. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52:490-494.
53. Francis GS. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 1986; 57:3B-7B.
54. Koehler U, Fus E, Grimm W, Pankow W, Schafer H, Stammintz A, Peter JH. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998; 11:434-439.
55. Stegman SS, Burroughs JM, Henthorn RW. Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin Electrophysiol 1996; 19:899-904.
56. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995; 108:625-630.
57. Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, Mishima M, Kuno K. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 153:1972-1976.
58. Genovese J, Huberfeld S, Tarasiuk A, Moskowitz M, Scharf SM. Effects of CPAP on cardiac output in pigs with pacing-induced congestive heart failure. Am J Respir Crit Care Med 1995; 152:1847-1853.
59. Krieger J, Grucker D, Sforza E. Left ventricular ejection fraction in obstructive sleep apnea: effects of long-term treatment with nasal continuous positive airway pressure. Chest 1991; 100:917-921.
60. Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Menn S. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18:501-510.
61. Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996; 109:1269-1275.
62. Pepin JL, Veale D, Mayer P, Bettega G, Wuyam B, Levy P. Critical analysis of the results of surgery in the treatment of snoring, upper airway resistance syndrome (UARS), and obstructive sleep apnea (OSA). Sleep 1996; 19:S90-S100.
63. Guilleminault C, Simmons FB, Motta J, Cummiskey J, Rosekind M, Schroeder JS, Dement WC. Obstructive sleep apnea syndrome and tracheostomy: long-term follow-up experience. Arch Intern Med 1981; 141:985-988.
64. Moser RJ, Rajagopal KR. Obstructive sleep apnea in adults with tonsillar hypertrophy. Arch Intern Med 1987; 147:1265-1267.
65. Walker RP, Grigg-Damberger MM, Gopalsami C. Uvulopalatopharyngoplasty versus laser-assisted uvulopalatoplasty for the treatment of obstructive sleep apnea. Laryngoscope 1997; 107:76-82.
66. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996; 19: 156-177.
67. Launois SH, Feroah TR, Campbell WN, Issa FG, Morrison D, Whitelaw WA, Isono S, Remmers JE. Site of pharyngeal narrowing predicts outcome of surgery for obstructive sleep apnea. Am Rev Respir Dis 1993; 147:182-189.
68. Rubinstein I, Bradley TD, Zamel N, Hoffstein V. Glottic and cervical tracheal narrowing in patients with obstructive sleep apnea. J Appl Physiol 1989; 67:24272431.
69. Heimer D, Scharf SM, Lieberman A, Lavie P. Sleep apnea syndrome treated by repair of deviated nasal septum. Chest 1983; 84:184-185.
70. Motta J, Guilleminault C, Schroeder JS, Dement WC. Tracheostomy and hemodynamic changes in sleep-inducing apnea. Ann Intern Med 1978; 89:454-458.
71. Harlid R, Andersson G, Frostell CG, Jorbeck HJ, Ortquist AB. Respiratory tract colonization and infection in patients with chronic tracheostomy: a one-year study in patients living at home. Am J Respir Crit Care Med 1996; 154:124-129.
72. Badr MS, Grossman JE, Weber SA. Treatment of refractory sleep apnea with supplemental carbon dioxide. Am J Respir Crit Care Med 1994; 150:561-564.
73. Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 1996; 154:376-381.
74. Naughton M, Benard D, Tam A, Rutherford R, Bradley TD. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 1993; 148:330-338.
75. Paintal AS. Mechanisms of stimulation of type J pulmonary receptors. J Physiol 1969; 203:511-532.
76. Sackner MA, Krieger BP. Noninvasive respiratory monitoring in Scharf SM, Cassidy SS, eds. Heart and Lung Interactions in Health and Disease. New York: Marcel Dekker, 1991: 663-805.
77. Dark DS, Pingleton SK, Kerby GR, Crabb JE, Gollub SB, Glatter TR, Dunn MI. Breathing pattern abnormalities and arterial oxygen desaturation during sleep in the congestive heart failure syndrome: improvement following medical therapy. Chest 1987; 91:833-836.
78. Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive heart failure. Heart 1995; 73:237-241.
79. Murdock DK, Lawless CE, Loeb HS, Scanlon PJ, Pifarre R. The effect of heart transplantation on Cheyne-Stokes respiration associated with congestive heart failure. J Heart Transplant 1986; 5:336-337.
80. Naughton MT, Benard DC, Rutherford R, Bradley TD. Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. Am J Respir Crit Care Med 1994; 150:1598-1604.
81. Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 1983; 55:813-822.
82. Torres A, Kamarek RM, Kimball WR, Qvist J, Stanek K, Whyte R, Zapol WM. Regional diaphragmatic length and EMG activity during inspiratory pressure support and CPAP in awake sheep. J Appl Physiol 1993; 74:695-703.
83. Benard DC, Naughton MT, Bradley TD. Administration of continuous positive airway pressure to patients with congestive heart failure and Cheyne-Stokes respiration. J Polysomnogr 1992; 9-11.
84. Guilleminault C, Clerk A, Labanowski M, Simmons J, Stoohs R. Cardiac failure and benzodiazepines. Sleep 1993; 16:524-528.
85. Davies RJO, Harrington KJ, Ormerod OJM, Stradling JR. Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis 1993; 147:630-634.
86. Buckle P, Millar T, Kryger M. The effect of short-term nasal CPAP on Cheyne-Stokes respiration in congestive heart failure. Chest 1992; 102:31-35.
87. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325:293-302.
88. Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA. Safety and efficacy of carvedilol in severe heart failure: the U.S. carvedilol heart failure study group. J Cardiac Failure 1997; 3:173-179.
89. McParand C, Krishnan B, Wang Y, Gallagher C. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992; 146:467-472.
90. Sullivan MJ, Green HJ, Cobb FK. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81:518-528.
91. Rasanen J, Heikkila J, Downs J, Nikki P, Vaisanen I, Vitanen A. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Am J Cardiol 1985; 55:296-300.
92. Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure: a double-blind, placebo controlled trial. Circulation 1989; 79:491-502.
93. Granton JT, Naughton MT, Benard DC, Liu PP, Goldstein RS, Bradley TD. CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1996; 153:277-282.
94. Veterans Administration Cooperative Study Group. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314:1547-1552.
95. Veterans Administration Cooperative Study Group. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310.
96. Tkacova R, Liu PP, Naughton MT, Bradley TD. Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure. J Am Coll Cardiol 1997; 30:739-745.
97. Vanoverschelde JLJ, Raphael DA, Robert DA, Cosyns JR. Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. J Am Coll Cardiol 1990; 15:1288-1295.
98. Weiland DS, Konstam MA, Salem DN, Martin TT, Cohen SR, Zile MR, Das D. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy: Am J Cardiol 1986; 58:1046-1050.
99. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989; 13: 1534-1539.
100. Daly PA, Sole MJ. Myocardial catecholamines and the pathophysiology of heart failure. Circulation 1990; 82:I35-I43.
101. Francis GS, McDonald KM, Cohn JN. Neurohumoral activation in preclinical heart failure: remodeling and the potential for intervention. Circulation 1993; 87:IV90-IV96.
102. Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819823.
103. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152:473-479.
104. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82:1730-1736.
105. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A and the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Circulation 1993; 87(suppl VI):40-48.
106. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335:562-567.
107. DeBacker WA, Verbraecken J, Willemen M, Wittesaele W, DeCock W, Van de-Heyning P. Central apnea index decreases after prolonged treatment with acetazo-lamide. Am J Respir Crit Care Med 1995; 151:87-91.
108. Lorenzi-Filho G, Rankin F, Bies I, Merson R, Rosenberg J, Bradley TD. Effects of inhaled CO2 and O2 on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999; 159:1490-1498.
109. Andreas S, Hagenah G, Moller C, Heindl S. Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Am J Respir Crit Care Med 1998; 157: A776.
110. Steens RD, Millar TW, Su X, Biberdorf D, Buckle P, Ahmed M, Kryger MH. Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure. Sleep 1994; 17:61-68.
111. Eldridge FL, Millhorn DE, Waldrop TG. Mechanism of respiratory effects of meth-ylxanthines. Respir Physiol 1983; 53:239-261.
112. Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989; 111:777-782.
113. Bittar G, Friedman HS. The arrhythmogenicity of theophylline: a multivariate analysis of clinical determinants. Chest 1991; 99:1415-1420.
114. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tan-don PK, DeMets DL. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325:1468-1475.
115. Dies F, Krell MJ, Whitlow P. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 1986; 74(suppl II):II-39.
116. White DP, Zwillich CW, Pickett CK, Douglas NJ, Findley LJ, Weil JV. Central sleep apnea: improvement with acetazolamide therapy. Arch Intern Med 1982; 142: 1816-1819.
117. Tojima H, Kunitomo F, Kimura H, Tatsumi K, Kuriyama T, Honda Y. Effects of acetazolamide inpatients with sleep apnoea syndrome. Thorax 1988; 43:113-119.
118. Bickler PE, Litt L, Banville D, Severinghaus JW. Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol 1988; 65:422-427.
119. Sakamoto T, Nakazawa Y, Hashizume Y, Tsutsumi Y, Mizuma H, Hirano T, Mukai M, Kotorii T. Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism. Psychiatry Clin Neurosci 1995; 49:59-64.
120. Xie A, Rutherford R, Rankin F, Wong B, Bradley TD. Hypocapnia and increased ventilatory responsiveness in patients with idiopathic central sleep apnea. Am J Respir Crit Care Med 1995; 152:1950-1955.
121. Xie A, Wong B, Phillipson EA, Slutsky AS, Bradley TD. Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 1994; 150:489-495.
122. Xie A, Rankin F, Rutherford R, Bradley TD. Effects of inhaled CO2 and added deadspace on idiopathic central sleep apnea. J Appl Physiol 1997; 82:918-926.
123. Bonnet MH, Dexter JR, Arand DL. The effect of triazolam on arousal and respiration in central sleep apnea. Sleep 1990; 13:31-41.
124. Dalen JE, Evans GL, Banas JS. The hemodynamic and respiratory effects of diazepam (Valium). Anesthesiology 1969; 30:259-263.
125. Biberdorf DJ, Steens R, Millar TW, Kryger MH. Benzodiazepines in congestive heart failure: effect of temazepam on arousabillity and Cheyne-Stokes respiration. Sleep 1993; 16:529-538.
126. Berssenbrugge A, Dempsey J, Iber C, Skatrud J, Wilson P. Mechanisms of hypoxia-induced periodic breathing during sleep in humans. J Physiol 1983; 343:507-524.
127. Franklin KA, Eriksson P, Sahlin C, Lundgren R. Reversal of central sleep apnea with oxygen. Chest 1997; 111:163-169.
128. Franklin KA, Sandstrom E, Johansson G, Balfors EM. Hemodynamics, cerebral circulation, and oxygen saturation in Cheyne-Stokes respiration. J Appl Physiol 1997; 83:1184-1191.
129. Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27:1486-1490.
130. Staniforth AD, Kinnear WJM, Starling R, Hetmanski DJ, Cowley AJ. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19: 922-928.
131. Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996; 27:353-357.